DZHK Seminar Serie 2017

07. Februar 2017, Wolfgang Bergmeier, Ass. Prof. Biochemistry and Biophysics  & Member of the McAllister Heart Institute, University of North Carolina at Chapel Hill, USA

04. April 2017, Prof. Dr. Dr. med. Stefan D. Anker, FESC, DZHK-Professor of Innovative Clinical Trials, University Medical Center Göttingen

25. April 2017, Prof. Seppo Ylä-Herttuala, University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences Department of Biotechnology and Molecular Medicine, Kuopio, Finland

09. September 2017, Prof. Norbert Hübner, MDC, Berlin

05. Oktober 2017, Prof. Dr. med. Thomas Eschenhagen, UKE, Hamburg

10. Oktober 2017, Dr. Ulrich Granzer, München

17. Oktober 2017, Prof. Dr. Dr. Stefan Engelhardt, TUM, München

24. Oktober 2017, Prof. David Eisner, Manchester

28. November 2017, Prof. Eva van Rooij, Hubrecht Instutute, The Netherlands

05. Dezember 2017, Prof. Lesca Holdt, München

12. Dezember 2017, Dr. Clinton Robbins, Toronto

30. Januar 2018, Prof. Stefanie Dimmeler, Frankfurt

DZHK Seminar Serie 2014

Prof. Andrew Baker, Institute of Cardiovascular and Medical Sciences BHF Glasgow, Cardiovascular Research Centre, Glasgow (13.05.2014)

Prof. Jens Kockskämper, Philipps-Universität Marburg, Fachbereich Pharmazie, Institut für Pharmakologie und Klinische Pharmazie Marburg (22.04.2014)

Dr. habil. Ralf Hofmann, Karlsruher Institut für Technologie, Institut für Photonenforschung und Synchrotronstrahlung Karlsruhe (01.04.2014)

Dr. Timothy McKinsey, Assoc Professor, Depertment of Medicine/Division of Cardiology, University of Colorado, Denver (11.03.2014)

Dr. Manfred Schmidt, NCT/DKFZ Heidelberg (18.02.2014)

Dr. Nina Ullrich, Institute of Physiology & Pathophysiology, Heidelberg (21.01.2014)

DZHK Seminar Serie 2013

Prof. Dr. med. Uwe Haberkorn, Director, Dept. Nuclear Medicine, University of Heidelberg, Head Clinical Cooperation Unit Nuclear Medicine, DKFZ Heidelberg

Prof. Manuel Mayr, King's British Heart Foundation Centre, King's College London, UK

Dr. Sandra Hoffmann, Department of Human Molecular Genetics, Heidelberg University

Dr. Carmen Ruiz de Almodovar,  Molecular and Cellular Mechanisms of the Neurovascular link, Biochemistry Center (BZH) Heidelberg

Prof. Thomas Wieland, Head, Institut of Experimental and Clinical Pharmacology and Toxicology, Mannheim

Prof. Stephan Herzig, Head, Division of Molecular Metabolic Control, DKFZ Heidelberg

Prof. Michael Boutros, Head, Division of Signaling and Functional Genomics, DKFZ Heidelberg

Prof. Eileen Furlong, Head of Genome Biology, EMBL Heidelberg

Prof. Christoph Plass, Head, Division of Epigenomics and Cancer Risk, DKFZ Heidelberg

Dr. Oliver Drews, Group Leader, Proteasomal Regulation in Cardiac Disease, Institute of Physiology and Pathophysiology, Department of Cardiovascular Physiology, University of Heidelberg

Departement Seminare - Cardiovascular Biology and Disease

PD Dr. med. Jochen Utikal, Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Mannheim (17.01.2012)

Dr. Dr. Melanie Boerries, Medicine and Cell Biology, Zentrum für Biosystemanalyse, Freiburg (14.02.2012)

Dr. med. Christoph Maack, Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes (20.03.2012)

Dr. Nicole Dubois, McEwen Centre for Regenerative Medicine Toronto (10.04.2012)

Prof. Dr. med. Christian Kupatt-Jeremias, Klinikum der Universität München (24.04.2012)

Prof. Dr. med. Ernst Niggli, Dep. of Physiology, University of Bern (10.07.2012)

Prof. Mark E. Anderson, University of Iowa, Internal Medicine and Molecular Physiology  & Biophysics (04.09.2012) 

Dr. Masaki Ieda, Keio University School of Medicine Tokyo (09.10.2012)

Wahlfach Molekulare Kardiologie 2014

Termin: 14. - 16. April 2014

Ort: Medizinische Klinik, INF 410, SR 718/719 und 703/704

Leitung und Organisation: Prof. Dr. med. Patrick Most

Anmeldefrist: 10. April 2014

Anmeldung: sekretariat.most(at)med.uni-heidelberg.de

Programm